FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of…
Simple Blood Test Aids Risk Assessment for Approximately 14 Million Eligible Patients in the United States Diabetic Kidney Disease is the Leading Cause of End Stage Kidney Disease in the…